John W. Kasckow, MD, PhD
- 2Articles
- 5.4KReads1
- 2009–2010Active
- 10Collaborators
- 102Citations2
About
John W. Kasckow, MD, PhD, has published research focused on the use of citalopram augmentation to address subthreshold and subsyndromal depressive symptoms and suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder. His work, appearing in Psychiatrist.com between 2009 and 2010, includes randomized controlled trials investigating pharmacologic strategies for these clinical populations. Collaborators on his studies have included Ian Fellows, Shahrokh Golshan, Sidney Zisook, Somaia Mohamed, and David Lehman.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
